Trade Ionis Pharmaceuticals, Inc. - IONS CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.15 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 51.87 |
| Open | 51.63 |
| 1-Year Change | 29.5% |
| Day's Range | 51 - 52.07 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jul 25, 2024 | 51.80 | 1.48 | 2.94% | 50.32 | 52.18 | 50.32 |
| Jul 24, 2024 | 50.65 | 0.42 | 0.84% | 50.23 | 50.91 | 49.95 |
| Jul 23, 2024 | 50.32 | -0.10 | -0.20% | 50.42 | 51.12 | 49.17 |
| Jul 22, 2024 | 50.53 | 2.13 | 4.40% | 48.40 | 51.07 | 48.40 |
| Jul 19, 2024 | 47.75 | 0.94 | 2.01% | 46.81 | 48.96 | 46.81 |
| Jul 18, 2024 | 47.15 | -0.86 | -1.79% | 48.01 | 48.09 | 46.52 |
| Jul 17, 2024 | 47.88 | -1.11 | -2.27% | 48.99 | 49.49 | 47.58 |
| Jul 16, 2024 | 49.79 | 0.62 | 1.26% | 49.17 | 50.56 | 48.46 |
| Jul 15, 2024 | 47.50 | 0.25 | 0.53% | 47.25 | 47.94 | 46.61 |
| Jul 12, 2024 | 47.89 | 1.34 | 2.88% | 46.55 | 48.18 | 46.55 |
| Jul 11, 2024 | 47.20 | -1.29 | -2.66% | 48.49 | 49.38 | 47.03 |
| Jul 10, 2024 | 47.79 | 0.66 | 1.40% | 47.13 | 48.09 | 46.70 |
| Jul 9, 2024 | 46.99 | 0.45 | 0.97% | 46.54 | 47.17 | 46.49 |
| Jul 8, 2024 | 47.19 | 0.99 | 2.14% | 46.20 | 47.26 | 45.24 |
| Jul 5, 2024 | 46.04 | 0.97 | 2.15% | 45.07 | 46.26 | 44.86 |
| Jul 3, 2024 | 45.37 | 1.46 | 3.32% | 43.91 | 45.77 | 43.91 |
| Jul 2, 2024 | 45.09 | -0.96 | -2.08% | 46.05 | 47.14 | 44.72 |
| Jul 1, 2024 | 47.04 | -0.22 | -0.47% | 47.26 | 48.55 | 46.04 |
| Jun 28, 2024 | 47.58 | 0.88 | 1.88% | 46.70 | 47.66 | 46.70 |
| Jun 27, 2024 | 47.17 | -0.14 | -0.30% | 47.31 | 47.71 | 46.92 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Ionis Pharmaceuticals Company profile
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; and Kynamro an oligonucleotide inhibitor for use in patients with homozygous familial hypercholesterolemia to reduce low density lipoprotein-cholesterol, apolipoprotein B, total cholesterol, and non-high density lipoprotein. It is also developing inotersen, an antisense drug Ionis to treat patients with hereditary transthyretin amyloidosis; and volanesorsen, an antisense drug for the treatment of familial chylomicronemia syndrome and familial partial lipodystrophy. In addition, the company is developing drugs for various indications, such as cardiometabolic diseases caused by lipid disorders; cardiovascular disease, clotting disorders, and Alzheimer's and Parkinson's diseases; and acromegaly, amyotrophic lateral sclerosis, beta-thalassemia, and Huntington's disease. Ionis Pharmaceuticals, Inc. has a collaboration agreement with AstraZeneca to discover and develop antisense therapies for treating cardiovascular and metabolic diseases, and cancer; and Biogen Inc. to develop and commercialize therapies for neurological disorders, SMA, and neurodegenerative diseases. The company was formerly known as Isis Pharmaceuticals, Inc. and changed its name to Ionis Pharmaceuticals, Inc. in December 2015. Ionis Pharmaceuticals, Inc. was founded in 1989 and is headquartered in Carlsbad, California.| Industry: | Biotechnology & Medical Research (NEC) |
2855 Gazelle Court
CARLSBAD
CALIFORNIA 92010
US
News
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com